Cargando…

Techniques for detecting chromosomal aberrations in myelodysplastic syndromes

Myelodysplastic syndromes (MDS) are a group of heterogeneous hematologic diseases. Chromosomal aberrations are important for the initiation, development, and progression of MDS. Detection of chromosomal abnormalities in MDS is important for categorization, risk stratification, therapeutic selection,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Qibin, Peng, Min, Chu, Yuxin, Huang, Shiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617543/ https://www.ncbi.nlm.nih.gov/pubmed/28977983 http://dx.doi.org/10.18632/oncotarget.17698

Ejemplares similares

Identify latent chromosomal aberrations relevant to myelodysplastic syndromes
por: Song, Qibin, et al.
Publicado: (2017)

Myelodysplastic syndromes: Biological and therapeutic consequences of the evolving molecular aberrations landscape
por: Schwind, Sebastian, et al.
Publicado: (2021)

Mechanistic Insights of Aberrant Splicing with Splicing Factor Mutations Found in Myelodysplastic Syndromes
por: Kataoka, Naoyuki, et al.
Publicado: (2021)

Detection of chromosome aberrations in interphase nuclei using fluorescence in situ hybridization technique.
por: Song, H. G., et al.
Publicado: (1993)

Aberrant Methylation-Mediated Suppression of APAF1 in Myelodysplastic Syndrome
por: Zaker, Farhad, et al.
Publicado: (2017)

The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome
por: Yang, Yi-Tsung, et al.
Publicado: (2018)

Phenotypic characterization of aberrant stem and progenitor cell populations in myelodysplastic syndromes
por: Ostendorf, Benjamin N., et al.
Publicado: (2018)

Contribution of Aberrant Toll Like Receptor Signaling to the Pathogenesis of Myelodysplastic Syndromes
por: Paracatu, Luana Chiquetto, et al.
Publicado: (2020)

Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations
por: Dutta, Sayantanee, et al.
Publicado: (2022)

Prognostic impact of immunophenotypic aberrancies of blasts in lower risk myelodysplastic syndrome
por: Corrao, Kristen, et al.
Publicado: (2022)

Dissecting the cell of origin of aberrant SALL4 expression in myelodysplastic syndrome
por: Tatetsu, Hiro, et al.
Publicado: (2023)

Chromosomal Aberrations in Cattle
por: Holečková, Beáta, et al.
Publicado: (2021)

Quantitative Detection of ID4 Gene Aberrant Methylation in the Differentiation of Myelodysplastic Syndrome from Aplastic Anemia
por: Li, Mian-Yang, et al.
Publicado: (2015)

Impact of Copy Neutral Loss of Heterozygosity and Total Genome Aberrations on Survival in Myelodysplastic Syndrome
por: Yeung, Cecilia, et al.
Publicado: (2017)

Myelodysplastic Syndromes and Metabolism
por: Balaian, Ekaterina, et al.
Publicado: (2021)

Genetics of Myelodysplastic Syndromes
por: Saygin, Caner, et al.
Publicado: (2021)

Chromosomal Abnormalities in Myelodysplastic Syndrome Patients in Upper Northern Thailand
por: Phrommin, Suphitcha, et al.
Publicado: (2020)

Chromosome Y loss and drivers of clonal hematopoiesis in myelodysplastic syndrome
por: Baliakas, Panagiotis, et al.
Publicado: (2021)

Molecular Targeted Therapy and Immunotherapy for Myelodysplastic Syndrome
por: Lee, Paul, et al.
Publicado: (2021)

Myelodysplastic syndromes and overlap syndromes
por: Chang, Yoon Hwan
Publicado: (2021)

Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progression
por: van Spronsen, Margot F., et al.
Publicado: (2023)

Catalog of Chromosome Aberrations in Cancer
por: Secker-Walker, Lorna M
Publicado: (1996)

Two-stage Approach for Detecting Aberration of Influenza-like Illness
por: Chan, Ta-Chien, et al.
Publicado: (2014)

Decitabine in the treatment of myelodysplastic syndromes
por: Saba, Hussain I
Publicado: (2007)

Immune Mechanisms in Myelodysplastic Syndrome
por: Glenthøj, Andreas, et al.
Publicado: (2016)

Hereditary Predispositions to Myelodysplastic Syndrome
por: Bannon, Sarah A., et al.
Publicado: (2016)

Prognostic Markers of Myelodysplastic Syndromes
por: Veryaskina, Yuliya Andreevna, et al.
Publicado: (2020)

Genetic basis of myelodysplastic syndromes
por: OGAWA, Seishi
Publicado: (2020)

TP53 in Myelodysplastic Syndromes
por: Jiang, Yan, et al.
Publicado: (2021)

Myelodysplastic Syndrome: Diagnosis and Screening
por: Tria, Francisco P., et al.
Publicado: (2022)

The Mesenchymal Niche in Myelodysplastic Syndromes
por: Friedrich, Chloé, et al.
Publicado: (2022)

Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome
por: Madan, Vikas, et al.
Publicado: (2015)

Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome
por: Suh, Koung Jin, et al.
Publicado: (2016)

Hypoplastic Myelodysplastic Syndromes: Just an Overlap Syndrome?
por: Fattizzo, Bruno, et al.
Publicado: (2021)

Diagnostics and Prognostication of Myelodysplastic Syndromes
por: Zini, Gina
Publicado: (2017)

Cytogenetic features in myelodysplastic syndromes
por: Haase, Detlef
Publicado: (2008)

New Treatments for Myelodysplastic Syndromes
por: D’Alò, Francesco, et al.
Publicado: (2010)

Molecular Pathogenesis of Myelodysplastic Syndromes
por: Visconte, Valeria, et al.
Publicado: (2014)

Emerging Therapies for the Myelodysplastic Syndromes
por: Canaani, Jonathan
Publicado: (2019)

Myelodysplastic syndrome with genetic predisposition
por: Park, Meerim
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_engu1uckqplcfoq3002ddhfahg